Indivior PLC Ordinary Shares (INDV NASDAQ) stock market data APIs
$15.1303
0.52(3.4%)
as of July 8, 2025
Try our APIs with
free plan!
Indivior PLC Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Indivior PLC, together with its subsidiaries, develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally. The company develops medicines to treat substance use disorders. Its core marketed products include SUBLOCADE buprenorphine extended-release monthly injections; SUBOXONE Film, a buprenorphine and naloxone sublingual film; SUBOXONE Tablet, a buprenorphine and naloxone sublingual tablet; and SUBUTEX Tablet, a buprenorphine sublingual tablet for the treatment of opioid use disorder (OUD). The company also offers OPVEE nasal spray for opioid overdose reversal. In addition, it is developing INDV-2000, a selective orexin-1 receptor antagonist that is in Phase 2 clinical trial for the treatment of moderate to severe OUD; and INDV-6001, a buprenorphine-based long-acting injectable for the treatment of OUD in collaboration with Alar Pharmaceuticals Inc. Indivior PLC was incorporated in 2014 and is headquartered in North Chesterfield, Virginia.
Prev. Close
15.1303
Open
15.6477
High
15.4725
Low
15.1746
52 wk Range
7.33-15.88
Market Cap
1 940 M
Shares Outstanding
125 M
Revenue
1 170 M
EPS
0.41
Beta
0.246
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Indivior PLC Ordinary Shares data using free add-ons & libraries
Get Indivior PLC Ordinary Shares Fundamental Data
Indivior PLC Ordinary Shares Fundamental data includes:
- Net Revenue: 1 170 M
- EBITDA: 309 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-09
- EPS/Forecast: 0.2867
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Indivior PLC Ordinary Shares News
New
Indivior Announces Inclusion in the U.S. Russell 2000 ® and 3000 ® Indexes
RICHMOND, Va., June 30, 2025 /PRNewswire/ -- Indivior PLC(Nasdaq / LSE: INDV) will be added as a member of the U.S. small-cap Russell 2000 ® Index, effective after the U.S. market opens today as par...
Indivior to join Russell 2000 Index
* Indivior (NASDAQ:INDV [https://seekingalpha.com/symbol/INDV]) will join [https://seekingalpha.com/pr/20151416-indivior-announces-inclusion-in-the-u-s-russell-2000-and-3000-indexes]the U.S. small-c...
Indivior Presents New Data at CPDD Demonstrating that High Buprenorphine Exposure May Improve Treatment Outcomes in High Fentanyl Users
A post-hoc analysis demonstrates that buprenorphine exposure with 300 mg SUBLOCADE ® (buprenorphine extended-release) may improve treatment outcomes among opioid use disorder (OUD) patients with heav...
Wise Plans to Shift Main Listing From London to US
(Bloomberg) -- Wise Plc is planning to list its shares in the US, the latest blow to London’s stock market. Most Read from Bloomberg ICE Moves to DNA-Test Families Targeted for Deportation with Ne...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
